So last month, the DEA quietly declared that all marijuana extracts would be classified as Schedule I drugs. This includes CBD oil, which is derived from cannabis, occurs naturally and is non-psychoactive meaning it does not cause a high. What CBD oil IS known for is its numerous medicinal benefits including treatment of epilepsy, cancer and Alzheimer’s. That’s right, the oil that causes no high but can reduce seizures in children battling epilepsy is now classified in the same category as LSD, heroin and ecstasy.
Well, just last Monday, it was reported that Britain’s Medicines & Healthcare products Regulatory Agency (MHRA) has decided to take a completely opposite approach and classify CBD oil as a medicine, you know, because of all the healing and supportive evidence and stuff.
An MHRA spokesperson stated via their website, “We have come to the opinion that products containing cannabidiol (CBD) used for medical purposes are a medicine…. the MHRA will now work with individual companies and trade bodies in relation to making sure products containing CBD, used for a medical purpose, which can be classified as medicines, satisfy the legal requirements of the Human Medicines Regulations 2012.”
The MHRA’s decision to reclassify CBD came after proper research and evidence was brought to light about the medicinal effects of cannabis from multiple studies. This means CBD products can now be legally distributed in the UK.
Here’s the thing, we have the same types of studies conducted here in the United States that produce the same results, yet we choose to ignore that evidence and cling to our dated and stubborn ways. High Times reported just last month that a study done at the University of Alabama found that “CBD oil reduces both the frequency and severity of seizures in children and adults with severe, intractable epilepsy. In two-thirds of the 81 participants, the severity was reduced by at least 50 percent.” Way to go, DEA.